Press Releases Congressional Committee Releases Report, Internal FDA Documents on Aduhelm December 29, 2022
Press Releases FDA Must Promptly Withdraw Approval of Medication for Prevention of Preterm Birth October 18, 2022
In the News STAT Opinion: NEJM, other journals: provide more transparency about conflicts of interest or don’t publish conflicted articles May 19, 2022
Press Releases Statement: FDA’s Reckless Decision to Approve Ineffective Alzheimer’s Disease Drug Causing Financial Pain for All Medicare Part B Beneficiaries November 15, 2021
Press Releases Statement: Inspector General’s Decision To Investigate FDA’s Inappropriately Close Collaboration With Biogen on the Alzheimer’s Disease Drug Aducanumab Is Long Overdue August 4, 2021
Press Releases Letter: Woodcock Must Be Investigated as Part of IG’s Probe Into Aducanumab’s Approval July 13, 2021
Press Releases Statement: Woodcock’s Role in Aducanumab’s Approval Must be Investigated as Part of IG Probe July 9, 2021